 The FDA has approved Daré Bioscience Inc NASDAQ: DARE Xaciato DARE-BV1 to treat bacterial vaginosis. Xaciato is a thermosetting bioadhesive hydrogel containing clindamycin phosphate 2 designed as a one-time vaginally-administered treatment for bacterial vaginosis. 